Generic Injectable Drugs Industry Research Report 2023
Generic injectable drugs refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.
The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.
Highlights
The global Generic Injectable Drugs market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In the segment of generic sterile injectable drugs, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Generic Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injectable Drugs.
The Generic Injectable Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Generic Injectable Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Generic Injectable Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Generic Injectable Drugs type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Generic Injectable Drugs are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Generic Injectable Drugs segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Generic Injectable Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Generic Injectable Drugs market.
Generic Injectable Drugs Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Generic Injectable Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Generic Injectable Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Generic Injectable Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Generic Injectable Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Generic Injectable Drugs.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Generic Injectable Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.
Highlights
The global Generic Injectable Drugs market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In the segment of generic sterile injectable drugs, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Generic Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injectable Drugs.
The Generic Injectable Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Generic Injectable Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Generic Injectable Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Hospira (Pfizer Inc.)
- Fresenius Kabi
- Sandoz (Novartis)
- Hikma Pharmaceuticals PLC
- Dr. Reddy’s Laboratories Ltd
- Grifols
- Nichi-Iko Group (Sagent)
- Teva Pharmaceutical
- Auromedics
- Sanofi
- Gland Pharma
- Endo International PLC
Global markets are presented by Generic Injectable Drugs type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Generic Injectable Drugs are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Generic Injectable Drugs segment by Type
- Small Molecule
- Large Molecule
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Generic Injectable Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Generic Injectable Drugs market.
Generic Injectable Drugs Segment by Application
- Oncology
- Anesthesia
- Anti-Infectives
- Parenteral Nutrition
- Cardiovascular Diseases
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Generic Injectable Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Generic Injectable Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Generic Injectable Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Generic Injectable Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Generic Injectable Drugs.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Generic Injectable Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
- What factors will challenge the Product Name market growth?
- Which end-use segment will expand at the fastest CAGR in the Product Name market?
- Which are the emerging players in the Product Name market?
- How concentrated is the Product Name market?
- Which factors are positively contributing to the Product Name market growth?
- Which are the novel product innovations in the Product Name market?
- Which product segment will emerge as the most lucrative in the Product Name market?
- Which factors are increasing the competition in the Product Name market?
- Which are the strategic measures taken by the Product Name industry players?
- Which region will witness inactive growth during the forecast period?
- What key trends are likely to emerge in the Product Name market in the coming years?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Generic Injectable Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Generic Injectable Drugs Revenue Market Share by Type (2018-2023)
Table 7. Global Generic Injectable Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Generic Injectable Drugs Revenue Market Share by Type (2024-2029)
Table 9. Global Generic Injectable Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Generic Injectable Drugs Revenue Market Share by Application (2018-2023)
Table 11. Global Generic Injectable Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Generic Injectable Drugs Revenue Market Share by Application (2024-2029)
Table 13. Global Generic Injectable Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Generic Injectable Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Generic Injectable Drugs Market Share by Region (2018-2023)
Table 16. Global Generic Injectable Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Generic Injectable Drugs Market Share by Region (2024-2029)
Table 18. Generic Injectable Drugs Market Trends
Table 19. Generic Injectable Drugs Market Drivers
Table 20. Generic Injectable Drugs Market Challenges
Table 21. Generic Injectable Drugs Market Restraints
Table 22. Global Top Generic Injectable Drugs Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Generic Injectable Drugs Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Generic Injectable Drugs Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Generic Injectable Drugs, Headquarters and Area Served
Table 26. Global Generic Injectable Drugs Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Generic Injectable Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Generic Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Generic Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Generic Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Generic Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Generic Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Generic Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Generic Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Generic Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Generic Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Generic Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Generic Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Generic Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Generic Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Generic Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Generic Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Hospira (Pfizer Inc.) Company Detail
Table 46. Hospira (Pfizer Inc.) Business Overview
Table 47. Hospira (Pfizer Inc.) Generic Injectable Drugs Product
Table 48. Hospira (Pfizer Inc.) Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 49. Hospira (Pfizer Inc.) Recent Development
Table 50. Fresenius Kabi Company Detail
Table 51. Fresenius Kabi Business Overview
Table 52. Fresenius Kabi Generic Injectable Drugs Product
Table 53. Fresenius Kabi Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 54. Fresenius Kabi Recent Development
Table 55. Sandoz (Novartis) Company Detail
Table 56. Sandoz (Novartis) Business Overview
Table 57. Sandoz (Novartis) Generic Injectable Drugs Product
Table 58. Sandoz (Novartis) Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 59. Sandoz (Novartis) Recent Development
Table 60. Hikma Pharmaceuticals PLC Company Detail
Table 61. Hikma Pharmaceuticals PLC Business Overview
Table 62. Hikma Pharmaceuticals PLC Generic Injectable Drugs Product
Table 63. Hikma Pharmaceuticals PLC Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 64. Hikma Pharmaceuticals PLC Recent Development
Table 65. Dr. Reddy’s Laboratories Ltd Company Detail
Table 66. Dr. Reddy’s Laboratories Ltd Business Overview
Table 67. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product
Table 68. Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 69. Dr. Reddy’s Laboratories Ltd Recent Development
Table 70. Grifols Company Detail
Table 71. Grifols Business Overview
Table 72. Grifols Generic Injectable Drugs Product
Table 73. Grifols Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 74. Grifols Recent Development
Table 75. Nichi-Iko Group (Sagent) Company Detail
Table 76. Nichi-Iko Group (Sagent) Business Overview
Table 77. Nichi-Iko Group (Sagent) Generic Injectable Drugs Product
Table 78. Nichi-Iko Group (Sagent) Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 79. Nichi-Iko Group (Sagent) Recent Development
Table 80. Teva Pharmaceutical Company Detail
Table 81. Teva Pharmaceutical Business Overview
Table 82. Teva Pharmaceutical Generic Injectable Drugs Product
Table 83. Teva Pharmaceutical Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 84. Teva Pharmaceutical Recent Development
Table 85. Auromedics Company Detail
Table 86. Auromedics Business Overview
Table 87. Auromedics Generic Injectable Drugs Product
Table 88. Auromedics Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 89. Auromedics Recent Development
Table 90. Sanofi Company Detail
Table 91. Sanofi Business Overview
Table 92. Sanofi Generic Injectable Drugs Product
Table 93. Sanofi Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 94. Sanofi Recent Development
Table 95. Gland Pharma Company Detail
Table 96. Gland Pharma Business Overview
Table 97. Gland Pharma Generic Injectable DrugsProduct
Table 98. Gland Pharma Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 99. Gland Pharma Recent Development
Table 100. Endo International PLC Company Detail
Table 101. Endo International PLC Business Overview
Table 102. Endo International PLC Generic Injectable DrugsProduct
Table 103. Endo International PLC Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 104. Endo International PLC Recent Development
Table 105. Hospira (Pfizer Inc.) Company Information
Table 106. Hospira (Pfizer Inc.) Business Overview
Table 107. Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 108. Hospira (Pfizer Inc.) Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 109. Hospira (Pfizer Inc.) Recent Development
Table 110. Fresenius Kabi Company Information
Table 111. Fresenius Kabi Business Overview
Table 112. Fresenius Kabi Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 113. Fresenius Kabi Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 114. Fresenius Kabi Recent Development
Table 115. Sandoz (Novartis) Company Information
Table 116. Sandoz (Novartis) Business Overview
Table 117. Sandoz (Novartis) Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 118. Sandoz (Novartis) Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 119. Sandoz (Novartis) Recent Development
Table 120. Hikma Pharmaceuticals PLC Company Information
Table 121. Hikma Pharmaceuticals PLC Business Overview
Table 122. Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 123. Hikma Pharmaceuticals PLC Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 124. Hikma Pharmaceuticals PLC Recent Development
Table 125. Dr. Reddy’s Laboratories Ltd Company Information
Table 126. Dr. Reddy’s Laboratories Ltd Business Overview
Table 127. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 128. Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 129. Dr. Reddy’s Laboratories Ltd Recent Development
Table 130. Grifols Company Information
Table 131. Grifols Business Overview
Table 132. Grifols Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 133. Grifols Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 134. Grifols Recent Development
Table 135. Nichi-Iko Group (Sagent) Company Information
Table 136. Nichi-Iko Group (Sagent) Business Overview
Table 137. Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 138. Nichi-Iko Group (Sagent) Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 139. Nichi-Iko Group (Sagent) Recent Development
Table 140. Teva Pharmaceutical Company Information
Table 141. Teva Pharmaceutical Business Overview
Table 142. Teva Pharmaceutical Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 143. Teva Pharmaceutical Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 144. Teva Pharmaceutical Recent Development
Table 145. Auromedics Company Information
Table 146. Auromedics Business Overview
Table 147. Auromedics Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 148. Auromedics Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 149. Auromedics Recent Development
Table 150. Sanofi Company Information
Table 151. Sanofi Business Overview
Table 152. Sanofi Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 153. Sanofi Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 154. Sanofi Recent Development
Table 155. Gland Pharma Company Information
Table 156. Gland Pharma Business Overview
Table 157. Gland Pharma Generic Injectable DrugsRevenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 158. Gland Pharma Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 159. Gland Pharma Recent Development
Table 160. Endo International PLC Company Information
Table 161. Endo International PLC Business Overview
Table 162. Endo International PLC Generic Injectable DrugsRevenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 163. Endo International PLC Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 164. Endo International PLC Recent Development
Table 165. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Generic Injectable Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Generic Injectable Drugs Revenue Market Share by Type (2018-2023)
Table 7. Global Generic Injectable Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Generic Injectable Drugs Revenue Market Share by Type (2024-2029)
Table 9. Global Generic Injectable Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Generic Injectable Drugs Revenue Market Share by Application (2018-2023)
Table 11. Global Generic Injectable Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Generic Injectable Drugs Revenue Market Share by Application (2024-2029)
Table 13. Global Generic Injectable Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Generic Injectable Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Generic Injectable Drugs Market Share by Region (2018-2023)
Table 16. Global Generic Injectable Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Generic Injectable Drugs Market Share by Region (2024-2029)
Table 18. Generic Injectable Drugs Market Trends
Table 19. Generic Injectable Drugs Market Drivers
Table 20. Generic Injectable Drugs Market Challenges
Table 21. Generic Injectable Drugs Market Restraints
Table 22. Global Top Generic Injectable Drugs Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Generic Injectable Drugs Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Generic Injectable Drugs Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Generic Injectable Drugs, Headquarters and Area Served
Table 26. Global Generic Injectable Drugs Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Generic Injectable Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Generic Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Generic Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Generic Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Generic Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Generic Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Generic Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Generic Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Generic Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Generic Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Generic Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Generic Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Generic Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Generic Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Generic Injectable Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Generic Injectable Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Hospira (Pfizer Inc.) Company Detail
Table 46. Hospira (Pfizer Inc.) Business Overview
Table 47. Hospira (Pfizer Inc.) Generic Injectable Drugs Product
Table 48. Hospira (Pfizer Inc.) Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 49. Hospira (Pfizer Inc.) Recent Development
Table 50. Fresenius Kabi Company Detail
Table 51. Fresenius Kabi Business Overview
Table 52. Fresenius Kabi Generic Injectable Drugs Product
Table 53. Fresenius Kabi Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 54. Fresenius Kabi Recent Development
Table 55. Sandoz (Novartis) Company Detail
Table 56. Sandoz (Novartis) Business Overview
Table 57. Sandoz (Novartis) Generic Injectable Drugs Product
Table 58. Sandoz (Novartis) Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 59. Sandoz (Novartis) Recent Development
Table 60. Hikma Pharmaceuticals PLC Company Detail
Table 61. Hikma Pharmaceuticals PLC Business Overview
Table 62. Hikma Pharmaceuticals PLC Generic Injectable Drugs Product
Table 63. Hikma Pharmaceuticals PLC Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 64. Hikma Pharmaceuticals PLC Recent Development
Table 65. Dr. Reddy’s Laboratories Ltd Company Detail
Table 66. Dr. Reddy’s Laboratories Ltd Business Overview
Table 67. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product
Table 68. Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 69. Dr. Reddy’s Laboratories Ltd Recent Development
Table 70. Grifols Company Detail
Table 71. Grifols Business Overview
Table 72. Grifols Generic Injectable Drugs Product
Table 73. Grifols Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 74. Grifols Recent Development
Table 75. Nichi-Iko Group (Sagent) Company Detail
Table 76. Nichi-Iko Group (Sagent) Business Overview
Table 77. Nichi-Iko Group (Sagent) Generic Injectable Drugs Product
Table 78. Nichi-Iko Group (Sagent) Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 79. Nichi-Iko Group (Sagent) Recent Development
Table 80. Teva Pharmaceutical Company Detail
Table 81. Teva Pharmaceutical Business Overview
Table 82. Teva Pharmaceutical Generic Injectable Drugs Product
Table 83. Teva Pharmaceutical Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 84. Teva Pharmaceutical Recent Development
Table 85. Auromedics Company Detail
Table 86. Auromedics Business Overview
Table 87. Auromedics Generic Injectable Drugs Product
Table 88. Auromedics Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 89. Auromedics Recent Development
Table 90. Sanofi Company Detail
Table 91. Sanofi Business Overview
Table 92. Sanofi Generic Injectable Drugs Product
Table 93. Sanofi Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 94. Sanofi Recent Development
Table 95. Gland Pharma Company Detail
Table 96. Gland Pharma Business Overview
Table 97. Gland Pharma Generic Injectable DrugsProduct
Table 98. Gland Pharma Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 99. Gland Pharma Recent Development
Table 100. Endo International PLC Company Detail
Table 101. Endo International PLC Business Overview
Table 102. Endo International PLC Generic Injectable DrugsProduct
Table 103. Endo International PLC Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 104. Endo International PLC Recent Development
Table 105. Hospira (Pfizer Inc.) Company Information
Table 106. Hospira (Pfizer Inc.) Business Overview
Table 107. Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 108. Hospira (Pfizer Inc.) Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 109. Hospira (Pfizer Inc.) Recent Development
Table 110. Fresenius Kabi Company Information
Table 111. Fresenius Kabi Business Overview
Table 112. Fresenius Kabi Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 113. Fresenius Kabi Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 114. Fresenius Kabi Recent Development
Table 115. Sandoz (Novartis) Company Information
Table 116. Sandoz (Novartis) Business Overview
Table 117. Sandoz (Novartis) Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 118. Sandoz (Novartis) Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 119. Sandoz (Novartis) Recent Development
Table 120. Hikma Pharmaceuticals PLC Company Information
Table 121. Hikma Pharmaceuticals PLC Business Overview
Table 122. Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 123. Hikma Pharmaceuticals PLC Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 124. Hikma Pharmaceuticals PLC Recent Development
Table 125. Dr. Reddy’s Laboratories Ltd Company Information
Table 126. Dr. Reddy’s Laboratories Ltd Business Overview
Table 127. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 128. Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 129. Dr. Reddy’s Laboratories Ltd Recent Development
Table 130. Grifols Company Information
Table 131. Grifols Business Overview
Table 132. Grifols Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 133. Grifols Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 134. Grifols Recent Development
Table 135. Nichi-Iko Group (Sagent) Company Information
Table 136. Nichi-Iko Group (Sagent) Business Overview
Table 137. Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 138. Nichi-Iko Group (Sagent) Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 139. Nichi-Iko Group (Sagent) Recent Development
Table 140. Teva Pharmaceutical Company Information
Table 141. Teva Pharmaceutical Business Overview
Table 142. Teva Pharmaceutical Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 143. Teva Pharmaceutical Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 144. Teva Pharmaceutical Recent Development
Table 145. Auromedics Company Information
Table 146. Auromedics Business Overview
Table 147. Auromedics Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 148. Auromedics Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 149. Auromedics Recent Development
Table 150. Sanofi Company Information
Table 151. Sanofi Business Overview
Table 152. Sanofi Generic Injectable Drugs Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 153. Sanofi Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 154. Sanofi Recent Development
Table 155. Gland Pharma Company Information
Table 156. Gland Pharma Business Overview
Table 157. Gland Pharma Generic Injectable DrugsRevenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 158. Gland Pharma Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 159. Gland Pharma Recent Development
Table 160. Endo International PLC Company Information
Table 161. Endo International PLC Business Overview
Table 162. Endo International PLC Generic Injectable DrugsRevenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million)
Table 163. Endo International PLC Revenue in Generic Injectable Drugs Business (2018-2023) & (US$ Million) Portfolio
Table 164. Endo International PLC Recent Development
Table 165. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Generic Injectable Drugs Product Picture
Figure 5. Global Generic Injectable Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Generic Injectable Drugs Market Share by Type: 2022 VS 2029
Figure 7. Small Molecule Product Picture
Figure 8. Large Molecule Product Picture
Figure 9. Global Generic Injectable Drugs Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Generic Injectable Drugs Market Share by Application: 2022 VS 2029
Figure 11. Oncology Product Picture
Figure 12. Anesthesia Product Picture
Figure 13. Anti-Infectives Product Picture
Figure 14. Parenteral Nutrition Product Picture
Figure 15. Cardiovascular Diseases Product Picture
Figure 16. Global Generic Injectable Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Generic Injectable Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Generic Injectable Drugs Market Share by Region: 2022 VS 2029
Figure 19. Global Generic Injectable Drugs Market Share by Players in 2022
Figure 20. Global Generic Injectable Drugs Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Generic Injectable Drugs Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Generic Injectable Drugs Market Share by Country (2018-2029)
Figure 25. United States Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Generic Injectable Drugs Market Share by Country (2018-2029)
Figure 29. Germany Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Generic Injectable Drugs Market Share by Country (2018-2029)
Figure 37. China Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Generic Injectable Drugs Market Share by Country (2018-2029)
Figure 45. Mexico Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Generic Injectable Drugs Market Share by Country (2018-2029)
Figure 49. Turkey Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Hospira (Pfizer Inc.) Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 53. Fresenius Kabi Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 54. Sandoz (Novartis) Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 55. Hikma Pharmaceuticals PLC Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 56. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 57. Grifols Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 58. Nichi-Iko Group (Sagent) Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 59. Teva Pharmaceutical Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 60. Auromedics Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 61. Sanofi Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 62. Gland Pharma Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 63. Endo International PLC Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Generic Injectable Drugs Product Picture
Figure 5. Global Generic Injectable Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Generic Injectable Drugs Market Share by Type: 2022 VS 2029
Figure 7. Small Molecule Product Picture
Figure 8. Large Molecule Product Picture
Figure 9. Global Generic Injectable Drugs Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Generic Injectable Drugs Market Share by Application: 2022 VS 2029
Figure 11. Oncology Product Picture
Figure 12. Anesthesia Product Picture
Figure 13. Anti-Infectives Product Picture
Figure 14. Parenteral Nutrition Product Picture
Figure 15. Cardiovascular Diseases Product Picture
Figure 16. Global Generic Injectable Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Generic Injectable Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Generic Injectable Drugs Market Share by Region: 2022 VS 2029
Figure 19. Global Generic Injectable Drugs Market Share by Players in 2022
Figure 20. Global Generic Injectable Drugs Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Generic Injectable Drugs Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Generic Injectable Drugs Market Share by Country (2018-2029)
Figure 25. United States Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Generic Injectable Drugs Market Share by Country (2018-2029)
Figure 29. Germany Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Generic Injectable Drugs Market Share by Country (2018-2029)
Figure 37. China Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Generic Injectable Drugs Market Share by Country (2018-2029)
Figure 45. Mexico Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Generic Injectable Drugs Market Share by Country (2018-2029)
Figure 49. Turkey Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Generic Injectable Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Hospira (Pfizer Inc.) Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 53. Fresenius Kabi Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 54. Sandoz (Novartis) Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 55. Hikma Pharmaceuticals PLC Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 56. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 57. Grifols Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 58. Nichi-Iko Group (Sagent) Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 59. Teva Pharmaceutical Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 60. Auromedics Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 61. Sanofi Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 62. Gland Pharma Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
Figure 63. Endo International PLC Revenue Growth Rate in Generic Injectable Drugs Business (2018-2023)
